EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies

Emily L Deichsel, Helen Powell, Christopher Troeger, M Jahangir Hossain, Samba O Sow, Richard Omore, Momodou Jasseh, Uma Onwuchekwa, David Obor, Doh Sanogo, Joquina Chiquita M Jones, Dilruba Nasrin und 2 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad015 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Emily L Deichsel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Rotavirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Statistical modeling suggests that decreasing diarrhea-associated mortality rates in recent decades are largely attributed to improved case management, rotavirus vaccine, and economic development.

Methods

We examined data collected in 2 multisite population-based diarrhea case-control studies, both conducted in The Gambia, Kenya, and Mali: the Global Enteric Multicenter Study (GEMS; 2008–2011) and Vaccine Impact on Diarrhea in Africa (VIDA; 2015–2018). Population-level diarrhea mortality and risk factor prevalence, estimated using these study data, were used to calculate the attribution of risk factors and interventions for diarrhea mortality using a counterfactual framework. We performed a decomposition of the effects of the changes in exposure to each risk factor between GEMS and VIDA on diarrhea mortality for each site.

Results

Diarrhea mortality among children under 5 in our African sites decreased by 65.3% (95% confidence interval [CI]: –80.0%, −45.0%) from GEMS to VIDA. Kenya and Mali had large relative declines in diarrhea mortality between the 2 periods with 85.9% (95% CI: −95.1%, −71.5%) and 78.0% (95% CI: −96.0%, 36.3%) reductions, respectively. Among the risk factors considered, the largest declines in diarrhea mortality between the 2 study periods were attributed to reduction in childhood wasting (27.2%; 95% CI: −39.3%, −16.8%) and an increased rotavirus vaccine coverage (23.1%; 95% CI: −28.4%, −19.4%), zinc for diarrhea treatment (12.1%; 95% CI: −16.0%, −8.9%), and oral rehydration salts (ORS) for diarrhea treatment (10.2%).

Conclusions

The VIDA study sites demonstrated exceptional reduction in diarrhea mortality over the last decade. Site-specific differences highlight an opportunity for implementation science in collaboration with policymakers to improve the equitable coverage of these interventions globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesRotavirus InfectionsChildHumansInfantDiarrheaRisk FactorsModels, StatisticalKenya

Stichwörter der Autor:innen

GEMSVIDArotavirus vaccine

Substanzen

Rotavirus Vaccines

Autor:innen und Institutionen

  • Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
  • Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
  • Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Förderung

  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation

Zitieren

APA

Deichsel, E. L., Powell, H., Troeger, C., Hossain, M. J., Sow, S. O., Omore, R., Jasseh, M., Onwuchekwa, U., Obor, D., Sanogo, D., Jones, J. C. M., Nasrin, D., Tapia, M. D., & Kotloff, K. L. (2023). Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad015

Vancouver

Deichsel EL, Powell H, Troeger C, Hossain MJ, Sow SO, Omore R, et al. Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad015

BibTeX
@article{Deichsel2023,
  author = {Deichsel, Emily L and Powell, Helen and Troeger, Christopher and Hossain, M Jahangir and Sow, Samba O and Omore, Richard and Jasseh, Momodou and Onwuchekwa, Uma and Obor, David and Sanogo, Doh and Jones, Joquina Chiquita M and Nasrin, Dilruba and Tapia, Milagritos D and Kotloff, Karen L},
  title = {Drivers of Decline in Diarrhea Mortality Between GEMS and VIDA Studies},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad015}
}
Kostenlos starten →